Shuttle Pharmaceuticals Holdings Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $0TTM through 31 Dec 2025
Net Income -$11.7MTTM through 31 Dec 2025
Free Cash Flow -$9.5MTTM through 31 Dec 2025
Margins
| Current |
|---|
Returns
-114.7%ROA
Balance Sheet Health
Debt / Equity0.10x
Current Ratio0.06x
Net Debt-$101.9Knet cash position
Cash & Equivalents$334K
Dividend
No dividend
Segment Performance
No segment data available.
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.